Nyxoah SA Current Ratio 2021-2024 | NYXH
Nyxoah SA Current Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets | Current Liabilities | Current Ratio |
2024-09-30 | $0.09B | $0.02B | 5.28 |
2024-06-30 | $0.10B | $0.02B | 5.47 |
2024-03-31 | $0.06B | $0.02B | 3.94 |
2023-12-31 | $0.07B | $0.02B | 4.73 |
2023-09-30 | $0.09B | $0.02B | 5.55 |
2023-06-30 | $0.10B | $0.02B | 5.99 |
2023-03-31 | $0.11B | $0.02B | 7.11 |
2022-12-31 | $0.11B | $0.02B | 6.72 |
2022-09-30 | $0.12B | $0.02B | 5.97 |
2022-06-30 | $0.14B | $0.02B | 7.24 |
2022-03-31 | $0.15B | $0.01B | 10.41 |
2021-12-31 | $0.00B | 0.00 | |
2021-06-30 | $0.10B | $0.02B | 6.68 |
2021-03-31 | $0.11B | $0.01B | 10.36 |
2020-12-31 | $0.11B | $0.01B | 14.70 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. |